Magdi Elsallab, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunotherapy, Adoptive | 6 | 2024 | 1520 | 1.270 |
Why?
|
| Accreditation | 1 | 2024 | 477 | 0.710 |
Why?
|
| Antigens, CD19 | 2 | 2023 | 446 | 0.710 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2024 | 496 | 0.700 |
Why?
|
| Hematologic Neoplasms | 2 | 2023 | 1907 | 0.680 |
Why?
|
| Marketing | 1 | 2020 | 224 | 0.580 |
Why?
|
| United States Food and Drug Administration | 2 | 2024 | 1672 | 0.540 |
Why?
|
| Neoplasms, Second Primary | 1 | 2024 | 1060 | 0.520 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2023 | 2574 | 0.500 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 1560 | 0.440 |
Why?
|
| Legislation, Drug | 1 | 2020 | 216 | 0.150 |
Why?
|
| Europe | 1 | 2020 | 3441 | 0.100 |
Why?
|
| T-Lymphocytes | 3 | 2023 | 10276 | 0.090 |
Why?
|
| Graft vs Host Disease | 1 | 2023 | 3048 | 0.090 |
Why?
|
| Biological Products | 1 | 2020 | 947 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 2018 | 1602 | 0.080 |
Why?
|
| Stem Cells | 2 | 2018 | 3539 | 0.080 |
Why?
|
| United States | 3 | 2024 | 73186 | 0.070 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 5716 | 0.060 |
Why?
|
| Humans | 11 | 2024 | 768970 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 812 | 0.040 |
Why?
|
| Adult | 2 | 2024 | 223851 | 0.040 |
Why?
|
| Therapies, Investigational | 1 | 2018 | 111 | 0.040 |
Why?
|
| Child | 1 | 2023 | 80960 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2021 | 1378 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 2018 | 785 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2018 | 831 | 0.030 |
Why?
|
| Databases, Factual | 2 | 2018 | 8094 | 0.030 |
Why?
|
| Neoplasms | 1 | 2021 | 22389 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 171786 | 0.020 |
Why?
|
| Middle Aged | 1 | 2024 | 223737 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 4794 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 5522 | 0.020 |
Why?
|
| Male | 1 | 2024 | 365203 | 0.020 |
Why?
|
| Female | 1 | 2024 | 397515 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 20245 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 8055 | 0.010 |
Why?
|